Weekly, paclitaxel plus carboplatin in patients with metastatic transitional cell carcinoma of the urothelium who failed MVAC: Phase II trial

被引：0
|
作者：
Kouno, T. [1 ]
Ando, M. [1 ]
Yonemori, K. [1 ]
Matsumoto, K. [1 ]
Komiyama, M. [1 ]
Okajima, E. [1 ]
Matsuoka, N. [1 ]
Fujimoto, H. [1 ]
Fujiwara, Y. [1 ]
机构：
[1] Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [31] Phase II trial of paclitaxel and acarboplatin in advanced/metastatic transitional cell cancer
    Wille, AH
    Johannsen, M
    Roigas, J
    Schnorr, D
    JOURNAL OF UROLOGY, 2004, 171 (04): : 84 - 85
  • [32] Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium: A phase-II study
    Popov, I
    Jelic, S
    Radosavljevic, D
    Nikolic-Tomasevic, Z
    EUROPEAN UROLOGY, 2001, 40 (03) : 324 - 329
  • [33] Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896) - A trial of the Eastern Cooperative Oncology Group
    Vaughn, DJ
    Manola, J
    Dreicer, R
    See, W
    Levitt, R
    Wilding, G
    CANCER, 2002, 95 (05) : 1022 - 1027
  • [34] A phase II evaluation of weekly paclitaxel plus carboplatin in advanced urothelial cancer
    Friedland, DM
    Dakhil, S
    Hollen, C
    Gregurich, MA
    Asmar, L
    CANCER INVESTIGATION, 2004, 22 (03) : 374 - 382
  • [35] Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma
    McCaffrey, JA
    Hilton, S
    Mazumdar, M
    Sadan, S
    Kelly, WK
    Scher, HI
    Bajorin, DF
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1853 - 1857
  • [36] Phase II trial of carboplatin/paclitaxel and cetuximab, followed by carboplatin/paclitaxel/cetuximab and erlotinib, in metastatic or recurrent squamous cell carcinoma of the head and neck.
    Bhatia, Aarti K.
    Mehra, Ranee
    Khan, Saad A.
    Egleston, Brian L.
    Alpaugh, R. Katherine
    Lango, Miriam
    Ridge, John A.
    Burtness, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma
    Tak Yun
    Ji-Youn Han
    Jin Soo Lee
    Hyun Lee Choi
    Hyae Young Kim
    Byung-Ho Nam
    Heung Tae Kim
    BMC Cancer, 11
  • [38] Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma
    Yun, Tak
    Han, Ji-Youn
    Lee, Jin Soo
    Choi, Hyun Lee
    Kim, Hyae Young
    Nam, Byung-Ho
    Kim, Heung Tae
    BMC CANCER, 2011, 11
  • [39] A PHASE-II STUDY OF CARBOPLATIN IN METASTATIC TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    不详
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (04): : 375 - 377
  • [40] Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer
    Burris, H
    Yardley, D
    Jones, S
    Houston, G
    Broome, C
    Thompson, D
    Greco, FA
    White, M
    Hainsworth, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) : 1621 - 1629
12345